The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Foreign body pulmonary vasculopathy (Excipient lung disease)
See PMID 34510050
Publications
Fatal Excipients: An Autopsy Case Series of Excipient Lung Disease.
The American journal of forensic medicine and pathology 2022 Mar 01;43;81-89 — 2022 Mar 01 — 81-89
Excipient-Induced Pulmonary Vascular Disease: An Underrecognized and Deadly Complication of Opioid Addiction.
Lung 2021 08;199;363-368 — 2021 08 — 363-368
Dyspnea and Pulmonary Hypertension with Diffuse Centrilobular Nodules.
Annals of the American Thoracic Society 2016 Oct;13;1858-1860 — 2016 Oct — 1858-1860